Sanguinarine Attenuates Neuropathic Pain by Inhibiting P38 MAPK Activated Neuroinflammation in Rat Model
Chao Yu,1,2,* Ping Li,3,* Yan-Xiu Wang,2 Kai-Gang Zhang,4 Zun-Cheng Zheng,3 Li-Shuang Liang5 1Department of Pain Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China; 2Department of Pain Medicine, Taian City Central Hospital...
Main Authors: | Yu C, Li P, Wang YX, Zhang KG, Zheng ZC, Liang LS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/sanguinarine-attenuates-neuropathic-pain-by-inhibiting-p38-mapk-activa-peer-reviewed-article-DDDT |
Similar Items
-
Preemptive intrathecal administration of endomorphins relieves inflammatory pain in male mice via inhibition of p38 MAPK signaling and regulation of inflammatory cytokines
by: Ting Zhang, et al.
Published: (2018-11-01) -
Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain
by: Renata Zajączkowska, et al.
Published: (2023-07-01) -
In vitro Anti-Inflammatory Potency of Sanguinarine and Chelerythrine via Interaction with Glucocorticoid Receptor
by: Jie Zhang, et al.
Published: (2021-01-01) -
Toxicological Effects of Berberine and Sanguinarine
by: Nitika Singh, et al.
Published: (2018-03-01) -
Antibacterial activity and mechanism of sanguinarine against Providencia rettgeri in vitro
by: Qian Zhang, et al.
Published: (2020-08-01)